|
Valganciclovir Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Also known as: Valcyte
Pipeline
Phase 2: 1
Top Sponsors
- The Methodist Hospital Research Institute1
Indications
- CMV Viremia1
- Brain Cancer Metastatic1
- Breast Cancer1
- Cancer1
Houston, Texas1 trial
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Houston Methodist Neal Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.